 |
FRISC: The Faculty Research Interests Science Comparator |
|
Professor of Internal Medicine
Biological Chemistry
Office: (214) 648-2890
FAX: (214) 648-4837
Email: grundy01@utsw.swmed.edu
Diagnosis and screening of coronary artery disease.
|
Score: 0.519 | |
The influence of dietary fat on insulin resistance.
|
Score: 0.493 | |
Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease.
|
Score: 0.463 | |
Metabolic syndrome.
|
Score: 0.460 | |
Insulin resistance in HIV-related lipodystrophy.
|
Score: 0.460 | |
The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
|
Score: 0.459 | |
Metabolic complications of obesity.
|
Score: 0.456 | |
Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
|
Score: 0.455 | |
Mouse models of lipodystrophy.
|
Score: 0.455 | |
Dietary lipids and gene expression.
|
Score: 0.454 | |
Dietary and lifestyle interventions in the management of the metabolic syndrome: present status and future perspective.
|
Score: 0.452 | |
Monounsaturated versus polyunsaturated dietary fat and serum lipids. A meta-analysis.
|
Score: 0.448 | |
Dietary fat, insulin sensitivity and the metabolic syndrome.
|
Score: 0.447 | |
[Insulin resistance: the adipose tissue in the focus]
|
Score: 0.439 | |
Is visceral obesity the cause of the metabolic syndrome?
|
Score: 0.438 | |
Adipose tissue and the insulin resistance syndrome.
|
Score: 0.438 | |
Preventing diabetes by treating aspects of the metabolic syndrome.
|
Score: 0.437 | |
Adiponectin, the missing link in insulin resistance and obesity.
|
Score: 0.437 | |
Overview: dietary approaches for reducing cardiovascular disease risks.
|
Score: 0.437 | |
The relationship of obesity to the metabolic syndrome.
|
Score: 0.435 | |
[Adipocytokins, obesity and development of type 2 diabetes]
|
Score: 0.435 | |
[Adipocytokins, obesity and development of type 2 diabetes]
|
Score: 0.435 | |
Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.
|
Score: 0.434 | |
Hypertriglyceridemia, insulin resistance, and the metabolic syndrome.
|
Score: 0.432 | |
Metabolic syndrome--new insights into a growing entity.
|
Score: 0.432 | |
The molecular basis of genetic lipodystrophies.
|
Score: 0.432 | |
Insulin resistance, hyperinsulinemia, and cardiovascular disease. The need for novel dietary prevention strategies.
|
Score: 0.431 | |
The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk.
|
Score: 0.427 | |
[Insulin resistance and hyperinsulinemia--clinical aspects]
|
Score: 0.425 | |
Review article: adipocytokines and insulin resistance.
|
Score: 0.424 | |
The metabolic syndrome: the crossroads of diet and genetics.
|
Score: 0.423 | |
Nutrition assessment in HIV infection.
|
Score: 0.423 | |
Fish oil.
|
Score: 0.422 | |
The optimal dietary strategy to manage risk associated with various dyslipidemias.
|
Score: 0.421 | |
Diet and risk of Type II diabetes: the role of types of fat and carbohydrate.
|
Score: 0.421 | |
Role of dietary fat in human nutrition. I. Role of unsaturated dietary fat in infant nutrition.
|
Score: 0.421 | |
Relation of components of insulin resistance syndrome to coronary disease risk.
|
Score: 0.420 | |
[Atherogenic dyslipidemia, metabolic syndrome and cardiovascular risk]
|
Score: 0.417 | |
Growth hormone and the metabolic syndrome.
|
Score: 0.416 | |
Metabolic syndrome.
|
Score: 0.416 | |
New directions in dietary studies of coronary heart disease.
|
Score: 0.415 | |
Molecular basis of partial lipodystrophy and prospects for therapy.
|
Score: 0.414 | |
Myocardial insulin resistance and cardiac complications of diabetes.
|
Score: 0.413 | |
The cardiovascular continuum in Asia--a new paradigm for the metabolic syndrome.
|
Score: 0.413 | |
[Obesity: entrance port to multimorbidity]
|
Score: 0.413 | |
Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia.
|
Score: 0.410 | |
Diet and Syndrome X.
|
Score: 0.410 | |
Dietary fat, fatty acid composition in plasma and the metabolic syndrome.
|
Score: 0.410 | |
The metabolic syndrome.
|
Score: 0.409 | |
Fatty acids and the metabolic syndrome.
|
Score: 0.408 | |
Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockade.
|
Score: 0.408 | |
Changing concepts in lipid nutrition in health and disease.
|
Score: 0.407 | |
Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity.
|
Score: 0.406 | |
Insulin resistance: concepts, controversies, and the role of nutrition.
|
Score: 0.406 | |
The metabolic syndrome: a crossroad for genotype-phenotype associations in atherosclerosis.
|
Score: 0.406 | |
Dietary fat quality and circulating cholesterol levels in humans: a review of actions and mechanisms.
|
Score: 0.406 | |
Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.
|
Score: 0.406 | |
[Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism]
|
Score: 0.405 | |
[How I study a patient with a low concentration of HDL cholesterol]
|
Score: 0.405 | |
The syndrome of insulin resistance.
|
Score: 0.405 | |
High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy.
|
Score: 0.403 | |
Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now?
|
Score: 0.403 | |
Hypercortisolism and obesity.
|
Score: 0.402 | |
Does dietary fat influence insulin action?
|
Score: 0.402 | |
Body fat distribution in females: metabolic consequences and implications for weight loss.
|
Score: 0.402 | |
Childhood weight and metabolic syndrome in adults.
|
Score: 0.402 | |
Insulin resistance-associated cardiovascular disease: potential benefits of conjugated linoleic acid.
|
Score: 0.402 | |
Obesity and common genetic metabolic disorders.
|
Score: 0.402 | |
Polyunsaturated and saturated fat, cholesterol, and fatty acid supplementation.
|
Score: 0.402 | |
Community interventions for cardiovascular disease.
|
Score: 0.402 | |
[Abdominal obesity and coronary heart disease. Pathophysiology and clinical significance]
|
Score: 0.401 | |
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies.
|
Score: 0.401 | |
Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy.
|
Score: 0.401 | |
[Diabetes and multimetabolic syndrome]
|
Score: 0.401 | |
Abdominal fat distribution and the metabolic syndrome.
|
Score: 0.400 | |
Obesity and the Metabolic Syndrome: implications for dietetics practitioners.
|
Score: 0.400 | |
Prospective analysis of the insulin-resistance syndrome (syndrome X).
|
Score: 0.399 | |
Obesity and the insulin resistance syndrome.
|
Score: 0.399 | |
Health consequences of fat distribution.
|
Score: 0.398 | |
[Abdominal obesity: metabolic complications and consequences for the liver]
|
Score: 0.398 | |
Emerging aspects of pharmacotherapy for obesity and metabolic syndrome.
|
Score: 0.398 | |
[Resistine--a new hormone secreted by adipose tissue (adipose tissue in insulin resistance)]
|
Score: 0.398 | |
Obesity, hypertension and insulin resistance.
|
Score: 0.398 | |
Dietary fats and coronary heart disease.
|
Score: 0.398 | |
Ischaemic heart disease as an effect of obesity-related metabolic disturbances.
|
Score: 0.397 | |
The Mediterranean diet: science and practice.
|
Score: 0.397 | |
Dietary fat, obesity and coronary heart disease.
|
Score: 0.397 | |
[ACE inhibitor in metabolic syndrome]
|
Score: 0.397 | |
Metabolic syndrome: historical perspectives.
|
Score: 0.396 | |
Phenomics, lipodystrophy, and the metabolic syndrome.
|
Score: 0.395 | |
[Metabolic syndrome: limited significance for clinical practice]
|
Score: 0.395 | |
Physical training and changes in regional adipose tissue distribution.
|
Score: 0.394 | |
Type of dietary fat and insulin resistance.
|
Score: 0.394 | |
The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals.
|
Score: 0.393 | |
Types of dietary fat and risk of coronary heart disease: a critical review.
|
Score: 0.393 | |
A scientific review: the role of chromium in insulin resistance.
|
Score: 0.393 | |
Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
|
Score: 0.392 | |
The metabolic role of n-3 polyunsaturated fatty acids: relationship to human disease.
|
Score: 0.392 | |
Diet and coronary heart disease. The National Heart Foundation of Australia.
|
Score: 0.392 | |
The metabolic syndrome: prevalence, CHD risk, and treatment.
|
Score: 0.391 | |
n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease.
|
Score: 0.391 | |
[Obesity and inflammation]
|
Score: 0.390 | |
Nursing sickness in the mink--a metabolic mystery or a familiar foe?
|
Score: 0.390 | |
[Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance]
|
Score: 0.389 | |
Clinical implications of the insulin resistance syndrome.
|
Score: 0.389 | |
Dyslipidaemia and obesity.
|
Score: 0.389 | |
Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity.
|
Score: 0.389 | |
Dietary habits and their association with metabolic abnormalities in human immunodeficiency virus-related lipodystrophy.
|
Score: 0.388 | |
Hypertriglyceridemia and risk of coronary heart disease.
|
Score: 0.388 | |
Insulin resistance syndrome: interaction with coagulation and fibrinolysis.
|
Score: 0.388 | |
Adipose tissue and metabolic effects: new insight into measurements.
|
Score: 0.387 | |
The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
|
Score: 0.387 | |
The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
|
Score: 0.387 | |
Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
|
Score: 0.387 | |
[Insulin resistance and metabolic syndrome]
|
Score: 0.387 | |
PAI-1, obesity, insulin resistance and risk of cardiovascular events.
|
Score: 0.386 | |
Muscle lipid metabolism in the metabolic syndrome.
|
Score: 0.386 | |
The perils of portliness: causes and consequences of visceral adiposity.
|
Score: 0.386 | |
Effects of polyunsaturated fatty acids on factors related to cardiovascular disease.
|
Score: 0.386 | |
Dietary treatment of the metabolic syndrome--the optimal diet.
|
Score: 0.385 | |
Insulin resistance: trigger or concomitant factor in the metabolic syndrome.
|
Score: 0.385 | |
Insulin resistance and chronic cardiovascular inflammatory syndrome.
|
Score: 0.385 | |
Insulin resistance and its treatment by thiazolidinediones.
|
Score: 0.385 | |
[Pathophysiologic principles of metabolic syndrome. Consequences for early diagnosis and prevention]
|
Score: 0.384 | |
Primary Na+/H+ exchanger dysfunction: a possible explanation for insulin resistance syndrome.
|
Score: 0.383 | |
DIETARY fat and coronary disease.
|
Score: 0.383 | |
[Insulin resistance, metabolic syndrome and cardiovascular diseases]
|
Score: 0.382 | |
General characteristics of the insulin resistance syndrome: prevalence and heritability. European Group for the study of Insulin Resistance (EGIR).
|
Score: 0.382 | |
[Bone metabolism in metabolic syndrome and its treatment]
|
Score: 0.382 | |
Abdominal obesity as important component of insulin-resistance syndrome.
|
Score: 0.382 | |
Lipid disorders in obesity.
|
Score: 0.382 | |
Cardiovascular risk associated with the metabolic syndrome.
|
Score: 0.381 | |
Hyperinsulinemia and its sequelae.
|
Score: 0.381 | |
A constellation of complications: the metabolic syndrome.
|
Score: 0.381 | |
The importance of body fat distribution in early life.
|
Score: 0.381 | |
Adiponectin, obesity, and cardiovascular disease.
|
Score: 0.381 | |
Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease.
|
Score: 0.381 | |
The metabolic syndrome and cardiovascular disease.
|
Score: 0.381 | |
Influence of diet on high-density lipoproteins.
|
Score: 0.380 | |
High-insulinogenic nutrition--an etiologic factor for obesity and the metabolic syndrome?
|
Score: 0.380 | |
The metabolic syndrome and cardiovascular disease.
|
Score: 0.380 | |
Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
|
Score: 0.379 | |
The metabolic syndrome.
|
Score: 0.379 | |
[Is the metabolic syndrome a new childhood disease?]
|
Score: 0.379 | |
Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
|
Score: 0.379 | |
Fat in the liver and insulin resistance.
|
Score: 0.378 | |
Lifestyle modifications for the prevention and treatment of cardiovascular disease: an evidence-based approach.
|
Score: 0.377 | |
Molecular mechanisms of insulin resistance that impact cardiovascular biology.
|
Score: 0.377 | |
Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones.
|
Score: 0.377 | |
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
|
Score: 0.377 | |
The role of increased liver triglyceride content: a culprit of diabetic hyperglycaemia?
|
Score: 0.377 | |
The optimal ratio of fat-to-carbohydrate in the diet.
|
Score: 0.377 | |
Role of dietary fat in human nutrition. II. Role of unsaturated fat in adult nutrition.
|
Score: 0.377 | |
Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.
|
Score: 0.376 | |
Angiotensin and insulin resistance: conspiracy theory.
|
Score: 0.376 | |
Molecular mechanisms for vascular injury in the metabolic syndrome.
|
Score: 0.375 | |
[Dyslipidemia]
|
Score: 0.375 | |
[Lipodystrophies]
|
Score: 0.375 | |
Lifestyle modification and endothelial function in obese subjects.
|
Score: 0.375 | |
The metabolic syndrome and inflammation: association or causation?
|
Score: 0.375 | |
Metabolic syndrome X: an inflammatory condition?
|
Score: 0.375 | |
Biological effects of fish oils in relation to chronic diseases.
|
Score: 0.375 | |
Dietary factors in the prevention of diabetes mellitus and coronary artery disease associated with the metabolic syndrome.
|
Score: 0.375 | |
[Metabolic syndrome and hyperlipidemia in HIV-positive patients]
|
Score: 0.375 | |
Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.
|
Score: 0.375 | |
Insulin resistance and lipid metabolism.
|
Score: 0.375 | |
Epidemiology of diabetes and obesity in the United States.
|
Score: 0.374 | |
[Metabolism of adipose tissue in normal humans and in various metabolic disorders. II. The adipose tissue in metabolic diseases]
|
Score: 0.374 | |
[Insulin resistance in non-alcoholic fatty liver disease]
|
Score: 0.374 | |
Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against.
|
Score: 0.374 | |
Hypertension, insulin resistance, and the metabolic syndrome.
|
Score: 0.374 | |
Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome.
|
Score: 0.374 | |
Protective effect of dietary monounsaturated fat on arteriosclerosis: beyond cholesterol.
|
Score: 0.373 | |
Obesity and nutrition in elderly diabetic patients.
|
Score: 0.373 | |
A changing role for dietary monounsaturated fatty acids.
|
Score: 0.373 | |
Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review.
|
Score: 0.373 | |
Genetic aspects of susceptibility to obesity and related dyslipidemias.
|
Score: 0.373 | |
Balanced intakes of natural triglycerides for optimum nutrition: an evolutionary and phytochemical perspective.
|
Score: 0.373 | |
CHOLESTEROL and fat metabolism in relation to nutrition and disease.
|
Score: 0.373 | |
The fatty liver and insulin resistance.
|
Score: 0.373 | |
Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
|
Score: 0.373 | |
Metabolic syndrome: therapeutic considerations.
|
Score: 0.373 | |
The insulin resistance epidemic in India: fetal origins, later lifestyle, or both?
|
Score: 0.373 | |
Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X.
|
Score: 0.372 | |
Small for gestational age and the metabolic syndrome: which mechanism is suggested by epidemiological and clinical studies?
|
Score: 0.372 | |
Plant-based foods and prevention of cardiovascular disease: an overview.
|
Score: 0.372 | |
Metabolic syndrome and effects of conjugated linoleic acid in obesity and lipoprotein disorders: the Québec experience.
|
Score: 0.372 | |
Adipokines: molecular links between obesity and atheroslcerosis.
|
Score: 0.372 | |
Insulin resistance in type 2 diabetes: role of fatty acids.
|
Score: 0.372 | |
Endocrine-metabolic pattern and adipose tissue distribution.
|
Score: 0.372 | |
Risk factor clusters for metabolic syndrome in coronary heart disease: state of the science.
|
Score: 0.372 | |
Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity.
|
Score: 0.371 | |
Metabolic abnormalities in cardiac ischemia.
|
Score: 0.371 | |
New aspects of insulin resistance in hypertension.
|
Score: 0.371 | |
[Grouping of risk factors for cardiovascular diseases in visceral obesity. Therapeutic implications]
|
Score: 0.371 | |
The obesity pandemic: where have we been and where are we going?
|
Score: 0.371 | |
The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
|
Score: 0.371 | |
Toward an improved diagnosis of the metabolic syndrome other clues to the presence of insulin resistance.
|
Score: 0.370 | |
The metabolic syndrome: an emerging health epidemic in women.
|
Score: 0.370 | |
Dietary treatment of thrombogenic disorders related to the metabolic syndrome.
|
Score: 0.370 | |
Association of syndromes of insulin resistance with coronary artery disease.
|
Score: 0.370 | |
Responses of serum lipoproteins to dietary cholesterol and type of fat in the baboon.
|
Score: 0.370 | |
[Disorder of carbohydrate metabolism]
|
Score: 0.370 | |
Metabolic syndrome: multiple candidate genes, multiple environmental factors--multiple syndromes?
|
Score: 0.370 | |
[Metabolic syndrome: to observe or to act?]
|
Score: 0.370 | |
[Metabolic or immunometabolic syndrome?]
|
Score: 0.369 | |
Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes.
|
Score: 0.369 | |
The effect of dietary fish oils on eicosanoid biosynthesis in peritoneal macrophages is influenced by both dietary N-6 polyunsaturated fats and total dietary fat.
|
Score: 0.369 | |
Dietary fat as a risk factor for type 2 diabetes.
|
Score: 0.369 | |
Adiponectin: linking the metabolic syndrome to its cardiovascular consequences.
|
Score: 0.369 | |
Influence of dietary carbohydrate and fat on LDL and HDL particle distributions.
|
Score: 0.369 | |
Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome.
|
Score: 0.369 | |
Phytosterols in the prevention of human pathologies.
|
Score: 0.368 | |
[The metabolic syndrome and insulin resistance]
|
Score: 0.368 | |
Cooking oils, cholesterol and CAD: facts and myths.
|
Score: 0.368 | |
Lipoproteins, nutrition, and heart disease.
|
Score: 0.368 | |
Insulin resistance, the metabolic syndrome and risk of cardiovascular disease: a complex story.
|
Score: 0.368 | |
Insulin therapy for reducing cardiovascular risk in patients with type 2 diabetes.
|
Score: 0.368 | |
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.
|
Score: 0.368 | |
Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
|
Score: 0.367 | |
Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?
|
Score: 0.367 | |
Metabolic syndrome: a new view of some familiar transplant risks.
|
Score: 0.367 | |
Insulin resistance: a metabolic pathway to chronic liver disease.
|
Score: 0.367 | |
Metabolic abnormalities in hypertension.
|
Score: 0.367 | |
Marine oils: metabolic effects and role in human nutrition.
|
Score: 0.366 | |
Nutritional management of plasma lipid disorders.
|
Score: 0.366 | |
[The role of dietary fats in health]
|
Score: 0.366 | |
Contribution of visceral obesity to the insulin resistance syndrome.
|
Score: 0.366 | |
Cellular, metabolic, and clinical consequences of adipose mass enlargement in obesity.
|
Score: 0.366 | |
Hyperlipidemia and diabetes: the role of dietary fats (continuing education credit).
|
Score: 0.365 | |
[Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data]
|
Score: 0.365 | |
Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes.
|
Score: 0.365 | |
Obesity and metabolic disease: is adipose tissue the culprit?
|
Score: 0.365 | |
[Chronic complications of polycystic ovary syndrome. Review]
|
Score: 0.365 | |
Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg.
|
Score: 0.365 | |
Dietary carbohydrates, physical inactivity, obesity, and the 'metabolic syndrome' as predictors of coronary heart disease.
|
Score: 0.365 | |
Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
|
Score: 0.365 | |
Hemodynamic and metabolic correlates in adipose tissue: pathophysiologic considerations.
|
Score: 0.365 | |
Fat and cancer.
|
Score: 0.365 | |
Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.
|
Score: 0.365 | |
Insulin resistance and the sympathetic nervous system.
|
Score: 0.365 | |
Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
|
Score: 0.365 | |
Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors.
|
Score: 0.365 | |
Does gastric restriction surgery reduce the risks of metabolic diseases?
|
Score: 0.364 | |
Epidemiology of the metabolic syndrome, 2002.
|
Score: 0.364 | |
Lipid overload and overflow: metabolic trauma and the metabolic syndrome.
|
Score: 0.364 | |
Dietary fat and coronary heart disease: a review.
|
Score: 0.364 | |
Role of macrophage tissue infiltration in metabolic diseases.
|
Score: 0.364 | |
Dietary fat and coronary heart disease.
|
Score: 0.364 | |
Dietary fat and coronary heart disease.
|
Score: 0.364 | |
Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
|
Score: 0.364 | |
Dietary fat and coronary heart disease.
|
Score: 0.364 | |
Dietary fat and coronary heart disease: a review.
|
Score: 0.364 | |
Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
|
Score: 0.363 | |
The insulin resistance syndrome and coronary artery disease.
|
Score: 0.363 | |
Insulin resistance and diabetes.
|
Score: 0.363 | |
Metabolic syndrome and risk of stroke.
|
Score: 0.363 | |
[Effects of aging on insulin resistance and fat accumulation]
|
Score: 0.363 | |
Traditional dietary adjuncts for the treatment of diabetes mellitus.
|
Score: 0.362 | |
Insulin resistance: causes and consequences.
|
Score: 0.362 | |
The central role of dietary fat, not carbohydrate, in the insulin resistance syndrome.
|
Score: 0.362 | |
Impact of obesity in primary hyperlipidemias.
|
Score: 0.362 | |
Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
|
Score: 0.362 | |
Cardiology. Diet, fat and diabetes.
|
Score: 0.362 | |
Contribution of CB1 blockade to the management of high-risk abdominal obesity.
|
Score: 0.362 | |
Metabolic syndrome: time for action.
|
Score: 0.362 | |
Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity.
|
Score: 0.362 | |
Nutrition in hereditary metabolic disease.
|
Score: 0.362 | |
Insulin sensitivity, muscle fibre types, and membrane lipids.
|
Score: 0.362 | |